((2S,4S)-4-Fluoro-1-methylpyrrolidin-2-yl)methanol, 98%, 500mg

N-Boc-3-Iodo-L-alanine benzyl ester, 98.0%, 5g

(R)-3-Ethoxypyrrolidine, 95.0%, 250mg

2-(5-Bromo-2,3-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

Syringe filters Minisart® NML with CE marking Sterile (gamma-sterilised), 0,45 µm, 50 Piece(s)

tert-butyl 3-hydrazinylpropanoate hydrochloride, 95.0%, 250mg

ACRIVASTINE, 95%, 250mg

Ethyl 3-bromo-2-oxocyclohexanecarboxylate, 95%, 1g

Ethyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 1g

Chlorogenic acid, 95.0%, 5g

2-(2-Fluorophenoxy)propanehydrazide, 97%, 250mg

6-chloro-2-(trifluoromethyl)-1,4-dihydroquinazolin-4-one, 95%, 5g

5'-Deoxy-5-fluorocytidine, 95.0%, 5g